Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Devilee

Showing results (81-90 of 282) with videos related to

Pageof 29
Sort By:
The Journal of Pathology|June 18, 2022
Minigene-based splicing analysis and ACMG/AMP-based tentative classification of 56 ATM variantsElena Bueno-Martínez, Lara Sanoguera-Miralles, Alberto Valenzuela-Palomo, et al.
Cancer Research|December 14, 2021
Functional Analysis Identifies Damaging CHEK2 Missense Variants Associated with Increased Cancer RiskRick A C M Boonen, Wouter W Wiegant, Nandi Celosse, et al.
BMC Cancer|July 25, 2008
A family history of breast cancer will not predict female early onset breast cancer in a population-based settingGeertruida H de Bock, Catharina E Jacobi, Caroline Seynaeve, et al.
Clinical Chemistry|September 19, 2023
Systematic Minigene-Based Splicing Analysis and Tentative Clinical Classification of 52 CHEK2 Splice-Site VariantsLara Sanoguera-Miralles, Alberto Valenzuela-Palomo, Elena Bueno-Martínez, et al.
Breast Cancer Research and Treatment|February 3, 2012
MUTYH gene variants and breast cancer in a Dutch case–control studyAstrid A Out, Marijke Wasielewski, Petra E A Huijts, et al.
Human Molecular Genetics|July 13, 2016
Parent-of-origin tumourigenesis is mediated by an essential imprinted modifier in SDHD-linked paragangliomas: SLC22A18 and CDKN1C are candidate tumour modifiersAttje S Hoekstra, Ruben D Addie, Cor Ras, et al.
Cancers|December 18, 2020
Comprehensive Functional Characterization and Clinical Interpretation of 20 Splice-Site Variants of the <i>RAD51C</i> GeneLara Sanoguera-Miralles, Alberto Valenzuela-Palomo, Elena Bueno-Martínez, et al.
European Journal of Human Genetics : EJHG|February 28, 2018
The association between cancer family history and ovarian cancer risk in BRCA1/2 mutation carriers: can it be explained by the mutation position?Natalia Teixeira, Annemieke van der Hout, Jan C Oosterwijk, et al.
Familial Cancer|March 3, 2007
Founder mutations in early-onset, familial and bilateral breast cancer patients from RussiaAnna P Sokolenko, Maxim E Rozanov, Natalia V Mitiushkina, et al.
The Journal of Pathology|November 30, 2021
Splicing predictions, minigene analyses, and ACMG-AMP clinical classification of 42 germline PALB2 splice-site variantsAlberto Valenzuela-Palomo, Elena Bueno-Martínez, Lara Sanoguera-Miralles, et al.
Pageof 29

Showing results (81-90 of 282) with videos related to

Sort By:
Pageof 29
The Journal of Pathology|June 18, 2022
Minigene-based splicing analysis and ACMG/AMP-based tentative classification of 56 ATM variantsElena Bueno-Martínez, Lara Sanoguera-Miralles, Alberto Valenzuela-Palomo, et al.
Cancer Research|December 14, 2021
Functional Analysis Identifies Damaging CHEK2 Missense Variants Associated with Increased Cancer RiskRick A C M Boonen, Wouter W Wiegant, Nandi Celosse, et al.
BMC Cancer|July 25, 2008
A family history of breast cancer will not predict female early onset breast cancer in a population-based settingGeertruida H de Bock, Catharina E Jacobi, Caroline Seynaeve, et al.
Clinical Chemistry|September 19, 2023
Systematic Minigene-Based Splicing Analysis and Tentative Clinical Classification of 52 CHEK2 Splice-Site VariantsLara Sanoguera-Miralles, Alberto Valenzuela-Palomo, Elena Bueno-Martínez, et al.
Breast Cancer Research and Treatment|February 3, 2012
MUTYH gene variants and breast cancer in a Dutch case–control studyAstrid A Out, Marijke Wasielewski, Petra E A Huijts, et al.
Human Molecular Genetics|July 13, 2016
Parent-of-origin tumourigenesis is mediated by an essential imprinted modifier in SDHD-linked paragangliomas: SLC22A18 and CDKN1C are candidate tumour modifiersAttje S Hoekstra, Ruben D Addie, Cor Ras, et al.
Cancers|December 18, 2020
Comprehensive Functional Characterization and Clinical Interpretation of 20 Splice-Site Variants of the <i>RAD51C</i> GeneLara Sanoguera-Miralles, Alberto Valenzuela-Palomo, Elena Bueno-Martínez, et al.
European Journal of Human Genetics : EJHG|February 28, 2018
The association between cancer family history and ovarian cancer risk in BRCA1/2 mutation carriers: can it be explained by the mutation position?Natalia Teixeira, Annemieke van der Hout, Jan C Oosterwijk, et al.
Familial Cancer|March 3, 2007
Founder mutations in early-onset, familial and bilateral breast cancer patients from RussiaAnna P Sokolenko, Maxim E Rozanov, Natalia V Mitiushkina, et al.
The Journal of Pathology|November 30, 2021
Splicing predictions, minigene analyses, and ACMG-AMP clinical classification of 42 germline PALB2 splice-site variantsAlberto Valenzuela-Palomo, Elena Bueno-Martínez, Lara Sanoguera-Miralles, et al.
Pageof 29